BioGeneration Ventures
oost has been involved in BGV as a venture partner for over 10 years. He is the former CEO of Cristal Therapeutics.
Joost started his career at Chiron in analytical and product development. He subsequently founded OctoPlus where he was the CEO for 14 years. During that time, he built up and successfully listed the company on Euronext. OctoPlus was acquired by Dr. Reddy’s in 2013.
Joost Holthuis is a pharmacist by training and holds a PhD from the University of Utrecht.
This person is not in any offices
BioGeneration Ventures
BioGeneration Ventures (BGV) is a venture capital company, with a focus on early stage European biotech, medtech, and diagnostics companies. BGV has a strong track record of significant financial returns through investing in innovations in healthcare and providing the expertise to build world-class teams. The Company manages over €100 million of funds investing in areas where true scientific innovations, the unmet medical need, and the potential to demonstrate a significant proof of concept all come together.